Wouter H. Moolenaar - Publications

Affiliations: 
Cellular Biochemistry NKI Netherlands Cancer Institute Amsterdam 

143 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Salgado-Polo F, van Veen M, van den Broek B, Jalink K, Leyton-Puig D, Perrakis A, Moolenaar WH, Matas-Rico E. Sequence-dependent trafficking and activity of GDE2, a GPI-specific phospholipase promoting neuronal differentiation. Journal of Cell Science. PMID 31932507 DOI: 10.1242/Jcs.235044  0.324
2018 Lin S, Haque A, Raeman R, Guo L, He P, Denning TL, El-Rayes B, Moolenaar WH, Yun CC. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801415RR. PMID 30481488 DOI: 10.1096/Fj.201801415Rr  0.338
2018 Argenzio E, Klarenbeek J, Kedziora KM, Nahidiazar L, Isogai T, Perrakis A, Jalink K, Moolenaar WH, Innocenti M. Profilin 1 binding couples chloride intracellular channel protein CLIC4 to RhoA-mDia2 signaling and filopodium formation. The Journal of Biological Chemistry. PMID 30381396 DOI: 10.1074/Jbc.Ra118.002779  0.411
2018 Argenzio E, Moolenaar WH, Verheij M. Abstract 5454: New insights into the mode of action of cytotoxic alkyl-phospholipids Cancer Research. 78: 5454-5454. DOI: 10.1158/1538-7445.Am2018-5454  0.387
2017 van Veen M, Mans LA, Matas-Rico E, van Pelt J, Perrakis A, Moolenaar WH, Haramis AG. Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish. The International Journal of Biochemistry & Cell Biology. 94: 71-78. PMID 29203233 DOI: 10.1016/J.Biocel.2017.11.015  0.341
2017 van Veen M, Matas-Rico E, van de Wetering K, Leyton-Puig D, Kedziora KM, De Lorenzi V, Stijf-Bultsma Y, van den Broek B, Jalink K, Sidenius N, Perrakis A, Moolenaar WH. Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells. Elife. 6. PMID 28849762 DOI: 10.7554/Elife.23649  0.419
2017 Veen Mv, Matas-Rico E, Wetering Kvd, Leyton-Puig D, Kedziora KM, Lorenzi VD, Stijf-Bultsma Y, Broek Bvd, Jalink K, Sidenius N, Perrakis A, Moolenaar WH. Author response: Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells Elife. DOI: 10.7554/Elife.23649.016  0.346
2016 Argenzio E, Moolenaar WH. Emerging biological roles of Cl- intracellular channel proteins. Journal of Cell Science. 129: 4165-4174. PMID 27852828 DOI: 10.1242/Jcs.189795  0.335
2016 Matas-Rico E, van Veen M, Leyton-Puig D, van den Berg J, Koster J, Kedziora KM, Molenaar B, Weerts MJ, de Rink I, Medema RH, Giepmans BN, Perrakis A, Jalink K, Versteeg R, Moolenaar WH. Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome. Cancer Cell. PMID 27693046 DOI: 10.1016/J.Ccell.2016.08.016  0.339
2016 Nishioka T, Arima N, Kano K, Hama K, Itai E, Yukiura H, Kise R, Inoue A, Kim SH, Solnica-Krezel L, Moolenaar WH, Chun J, Aoki J. ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation. Scientific Reports. 6: 23433. PMID 27005960 DOI: 10.1038/Srep23433  0.421
2016 Kedziora KM, Leyton-Puig D, Argenzio E, Boumeester AJ, van Butselaar B, Yin T, Wu YI, van Leeuwen FN, Innocenti M, Jalink K, Moolenaar WH. Rapid remodeling of invadosomes by Gi-coupled receptors: dissecting the role of Rho GTPases. The Journal of Biological Chemistry. PMID 26740622 DOI: 10.1074/Jbc.M115.695940  0.467
2014 Argenzio E, Margadant C, Leyton-Puig D, Janssen H, Jalink K, Sonnenberg A, Moolenaar WH. CLIC4 regulates cell adhesion and β1 integrin trafficking. Journal of Cell Science. 127: 5189-203. PMID 25344254 DOI: 10.1242/Jcs.150623  0.401
2014 Perrakis A, Moolenaar WH. Autotaxin: structure-function and signaling. Journal of Lipid Research. 55: 1010-8. PMID 24548887 DOI: 10.1194/Jlr.R046391  0.392
2013 Elouarrat D, van der Velden YU, Jones DR, Moolenaar WH, Divecha N, Haramis AP. Role of phosphatidylinositol 5-phosphate 4-kinase α in zebrafish development. The International Journal of Biochemistry & Cell Biology. 45: 1293-301. PMID 23542014 DOI: 10.1016/J.Biocel.2013.03.009  0.596
2013 Houben AJ, van Wijk XM, van Meeteren LA, van Zeijl L, van de Westerlo EM, Hausmann J, Fish A, Perrakis A, van Kuppevelt TH, Moolenaar WH. The polybasic insertion in autotaxin α confers specific binding to heparin and cell surface heparan sulfate proteoglycans. The Journal of Biological Chemistry. 288: 510-9. PMID 23150666 DOI: 10.1074/Jbc.M112.358416  0.35
2013 Hausmann J, Perrakis A, Moolenaar WH. Structure-function relationships of autotaxin, a secreted lysophospholipase D Advances in Biological Regulation. 53: 112-117. PMID 23069371 DOI: 10.1016/J.Jbior.2012.09.010  0.392
2013 Moolenaar WH, Houben AJ, Lee SJ, van Meeteren LA. Autotaxin in embryonic development. Biochimica Et Biophysica Acta. 1831: 13-9. PMID 23022664 DOI: 10.1016/J.Bbalip.2012.09.013  0.364
2012 Lai SL, Yao WL, Tsao KC, Houben AJ, Albers HM, Ovaa H, Moolenaar WH, Lee SJ. Autotaxin/Lpar3 signaling regulates Kupffer's vesicle formation and left-right asymmetry in zebrafish. Development (Cambridge, England). 139: 4439-48. PMID 23095890 DOI: 10.1242/Dev.081745  0.33
2012 Moolenaar WH, Hla T. SnapShot: Bioactive lysophospholipids. Cell. 148: 378-378.e2. PMID 22265422 DOI: 10.1016/J.Cell.2012.01.013  0.362
2011 Jongsma M, Matas-Rico E, Rzadkowski A, Jalink K, Moolenaar WH. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. Plos One. 6: e29260. PMID 22195035 DOI: 10.1371/Journal.Pone.0029260  0.48
2011 Houben AJ, Moolenaar WH. Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Reviews. 30: 557-65. PMID 22002750 DOI: 10.1007/S10555-011-9319-7  0.419
2011 Moolenaar WH, Perrakis A. Insights into autotaxin: how to produce and present a lipid mediator. Nature Reviews. Molecular Cell Biology. 12: 674-9. PMID 21915140 DOI: 10.1038/Nrm3188  0.439
2011 Hausmann J, Kamtekar S, Christodoulou E, Day JE, Wu T, Fulkerson Z, Albers HM, van Meeteren LA, Houben AJ, van Zeijl L, Jansen S, Andries M, Hall T, Pegg LE, Benson TE, ... ... Moolenaar WH, et al. Structural basis of substrate discrimination and integrin binding by autotaxin. Nature Structural & Molecular Biology. 18: 198-204. PMID 21240271 DOI: 10.1038/Nsmb.1980  0.365
2010 Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacological Reviews. 62: 579-87. PMID 21079037 DOI: 10.1124/Pr.110.003111  0.393
2010 Cavalli S, Houben AJ, Albers HM, van Tilburg EW, de Ru A, Aoki J, van Veelen P, Moolenaar WH, Ovaa H. Development of an activity-based probe for autotaxin. Chembiochem : a European Journal of Chemical Biology. 11: 2311-7. PMID 20941725 DOI: 10.1002/Cbic.201000349  0.346
2010 Albers HM, van Meeteren LA, Egan DA, van Tilburg EW, Moolenaar WH, Ovaa H. Discovery and optimization of boronic acid based inhibitors of autotaxin. Journal of Medicinal Chemistry. 53: 4958-67. PMID 20536182 DOI: 10.1021/Jm1005012  0.331
2010 Albers HM, Dong A, van Meeteren LA, Egan DA, Sunkara M, van Tilburg EW, Schuurman K, van Tellingen O, Morris AJ, Smyth SS, Moolenaar WH, Ovaa H. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proceedings of the National Academy of Sciences of the United States of America. 107: 7257-62. PMID 20360563 DOI: 10.1073/Pnas.1001529107  0.352
2010 Jalink K, Moolenaar WH. G protein-coupled receptors: the inside story. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 32: 13-6. PMID 20020476 DOI: 10.1002/Bies.200900153  0.416
2009 Ponsioen B, van Zeijl L, Langeslag M, Berryman M, Littler D, Jalink K, Moolenaar WH. Spatiotemporal regulation of chloride intracellular channel protein CLIC4 by RhoA. Molecular Biology of the Cell. 20: 4664-72. PMID 19776349 DOI: 10.1091/Mbc.E09-06-0529  0.391
2009 Jonkers J, Moolenaar WH. Mammary tumorigenesis through LPA receptor signaling. Cancer Cell. 15: 457-9. PMID 19477423 DOI: 10.1016/J.Ccr.2009.05.003  0.393
2009 Pamuklar Z, Federico L, Liu S, Umezu-Goto M, Dong A, Panchatcharam M, Fulkerson Z, Fulerson Z, Berdyshev E, Natarajan V, Fang X, van Meeteren LA, Moolenaar WH, Mills GB, Morris AJ, et al. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. The Journal of Biological Chemistry. 284: 7385-94. PMID 19139100 DOI: 10.1074/Jbc.M807820200  0.325
2008 Taghavi P, Verhoeven E, Jacobs JJ, Lambooij JP, Stortelers C, Tanger E, Moolenaar WH, van Lohuizen M. In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene. 27: 6806-16. PMID 18762810 DOI: 10.1038/Onc.2008.294  0.381
2008 Kortlever RM, Brummelkamp TR, van Meeteren LA, Moolenaar WH, Bernards R. Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling. Molecular Cancer Research : McR. 6: 1452-60. PMID 18723828 DOI: 10.1158/1541-7786.Mcr-08-0066  0.436
2008 Stortelers C, Kerkhoven R, Moolenaar WH. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling. Bmc Genomics. 9: 387. PMID 18702810 DOI: 10.1186/1471-2164-9-387  0.437
2008 van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer Letters. 266: 203-8. PMID 18378389 DOI: 10.1016/J.Canlet.2008.02.052  0.376
2007 van Zeijl L, Ponsioen B, Giepmans BN, Ariaens A, Postma FR, Várnai P, Balla T, Divecha N, Jalink K, Moolenaar WH. Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate. The Journal of Cell Biology. 177: 881-91. PMID 17535964 DOI: 10.1083/Jcb.200610144  0.632
2007 van Meeteren LA, Moolenaar WH. Regulation and biological activities of the autotaxin-LPA axis. Progress in Lipid Research. 46: 145-60. PMID 17459484 DOI: 10.1016/J.Plipres.2007.02.001  0.439
2007 Savaskan NE, Rocha L, Kotter MR, Baer A, Lubec G, van Meeteren LA, Kishi Y, Aoki J, Moolenaar WH, Nitsch R, Bräuer AU. Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cellular and Molecular Life Sciences : Cmls. 64: 230-43. PMID 17192809 DOI: 10.1007/S00018-006-6412-0  0.669
2007 Ponsioen B, van Zeijl L, Moolenaar WH, Jalink K. Direct measurement of cyclic AMP diffusion and signaling through connexin43 gap junctional channels. Experimental Cell Research. 313: 415-23. PMID 17150212 DOI: 10.1016/J.Yexcr.2006.10.029  0.4
2007 Langeslag M, Clark K, Moolenaar WH, van Leeuwen FN, Jalink K. Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. The Journal of Biological Chemistry. 282: 232-9. PMID 17095511 DOI: 10.1074/Jbc.M605300200  0.409
2006 van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradère JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Molecular and Cellular Biology. 26: 5015-22. PMID 16782887 DOI: 10.1128/Mcb.02419-05  0.364
2006 van Rossum AG, Moolenaar WH, Schuuring E. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Experimental Cell Research. 312: 1658-70. PMID 16527272 DOI: 10.1016/J.Yexcr.2006.01.033  0.357
2006 Sayas CL, Ariaens A, Ponsioen B, Moolenaar WH. GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction. Molecular Biology of the Cell. 17: 1834-44. PMID 16452634 DOI: 10.1091/Mbc.E05-07-0688  0.409
2006 Clark K, Langeslag M, van Leeuwen B, Ran L, Ryazanov AG, Figdor CG, Moolenaar WH, Jalink K, van Leeuwen FN. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. The Embo Journal. 25: 290-301. PMID 16407977 DOI: 10.1038/Sj.Emboj.7600931  0.387
2005 Mulder J, Ariaens A, van Horck FP, Moolenaar WH. Inhibition of RhoA-mediated SRF activation by p116Rip. Febs Letters. 579: 6121-7. PMID 16243315 DOI: 10.1016/J.Febslet.2005.09.083  0.369
2005 Durgam GG, Virag T, Walker MD, Tsukahara R, Yasuda S, Liliom K, van Meeteren LA, Moolenaar WH, Wilke N, Siess W, Tigyi G, Miller DD. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin. Journal of Medicinal Chemistry. 48: 4919-30. PMID 16033271 DOI: 10.1021/Jm049609R  0.394
2004 Ponsioen B, Zhao J, Riedl J, Zwartkruis F, van der Krogt G, Zaccolo M, Moolenaar WH, Bos JL, Jalink K. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. Embo Reports. 5: 1176-80. PMID 15550931 DOI: 10.1038/Sj.Embor.7400290  0.349
2004 Mulder J, Ariaens A, van den Boomen D, Moolenaar WH. p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis. Molecular Biology of the Cell. 15: 5516-27. PMID 15469989 DOI: 10.1091/Mbc.E04-04-0275  0.408
2004 Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 26: 870-81. PMID 15273989 DOI: 10.1002/bies.20081  0.315
2004 van Meeteren LA, Frederiks F, Giepmans BN, Pedrosa MF, Billington SJ, Jost BH, Tambourgi DV, Moolenaar WH. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. The Journal of Biological Chemistry. 279: 10833-6. PMID 14732720 DOI: 10.1074/Jbc.C300563200  0.374
2004 Moolenaar WH. LPA: a novel lipid mediator with diverse biological actions. Trends in Cell Biology. 4: 213-9. PMID 14731680 DOI: 10.1016/0962-8924(94)90144-9  0.432
2004 van Leeuwen FN, Giepmans BN, van Meeteren LA, Moolenaar WH. Lysophosphatidic acid: mitogen and motility factor. Biochemical Society Transactions. 31: 1209-12. PMID 14641027 DOI: 10.1042/BST0311209  0.358
2003 Giepmans BN, Feiken E, Gebbink MF, Moolenaar WH. Association of connexin43 with a receptor protein tyrosine phosphatase. Cell Communication & Adhesion. 10: 201-5. PMID 14681016 DOI: 10.1080/Cac.10.4-6.201.205  0.433
2003 van Rossum AG, de Graaf JH, Schuuring-Scholtes E, Kluin PM, Fan YX, Zhan X, Moolenaar WH, Schuuring E. Alternative splicing of the actin binding domain of human cortactin affects cell migration. The Journal of Biological Chemistry. 278: 45672-9. PMID 12952985 DOI: 10.1074/Jbc.M306688200  0.344
2003 Koop EA, Lopes SM, Feiken E, Bluyssen HA, van der Valk M, Voest EE, Mummery CL, Moolenaar WH, Gebbink MF. Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. The International Journal of Developmental Biology. 47: 345-54. PMID 12895029 DOI: 10.1387/Ijdb.12895029  0.35
2003 Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nature Reviews. Cancer. 3: 582-91. PMID 12894246 DOI: 10.1038/Nrc1143  0.389
2003 Mulder J, Poland M, Gebbink MF, Calafat J, Moolenaar WH, Kranenburg O. p116Rip is a novel filamentous actin-binding protein. The Journal of Biological Chemistry. 278: 27216-23. PMID 12732640 DOI: 10.1074/Jbc.M302399200  0.327
2003 Van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, Moolenaar WH. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. The Journal of Biological Chemistry. 278: 400-6. PMID 12393875 DOI: 10.1074/Jbc.M210151200  0.489
2003 Giepmans BN, Verlaan I, Moolenaar WH. Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Communication & Adhesion. 8: 219-23. PMID 12064592 DOI: 10.3109/15419060109080727  0.344
2002 Ruiter GA, Verheij M, Zerp SF, Moolenaar WH, Van Blitterswijk WJ. Submicromolar doses of alkyl-lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cells. International Journal of Cancer. Journal International Du Cancer. 102: 343-50. PMID 12402303 DOI: 10.1002/Ijc.10741  0.421
2002 Moolenaar WH. Lysophospholipids in the limelight: autotaxin takes center stage. The Journal of Cell Biology. 158: 197-9. PMID 12135981 DOI: 10.1083/Jcb.200206094  0.423
2002 Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacological Reviews. 54: 265-9. PMID 12037142 DOI: 10.1124/Pr.54.2.265  0.409
2002 van Horck FP, Lavazais E, Eickholt BJ, Moolenaar WH, Divecha N. Essential role of type I(alpha) phosphatidylinositol 4-phosphate 5-kinase in neurite remodeling. Current Biology : Cb. 12: 241-5. PMID 11839279 DOI: 10.1016/S0960-9822(01)00660-1  0.651
2002 Kranenburg O, Verlaan I, Moolenaar WH. Regulating c-Ras function. cholesterol depletion affects caveolin association, GTP loading, and signaling. Current Biology : Cb. 11: 1880-4. PMID 11728312 DOI: 10.1016/S0960-9822(01)00582-6  0.307
2001 Giepmans BNG, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM, Moolenaar WH. Gap junction protein connexin-43 interacts directly with microtubules Current Biology. 11: 1364-1368. PMID 11553331 DOI: 10.1016/S0960-9822(01)00424-9  0.347
2001 Kranenburg O, Moolenaar WH. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene. 20: 1540-6. PMID 11313900 DOI: 10.1038/Sj.Onc.1204187  0.42
2001 Postma FR, Jalink K, Hengeveld T, Offermanns S, Moolenaar WH. Galpha(13) mediates activation of a depolarizing chloride current that accompanies RhoA activation in both neuronal and nonneuronal cells. Current Biology : Cb. 11: 121-4. PMID 11231129 DOI: 10.1016/S0960-9822(01)00030-6  0.407
2000 Giepmans BN, Hengeveld T, Postma FR, Moolenaar WH. Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. The Journal of Biological Chemistry. 276: 8544-9. PMID 11124251 DOI: 10.1074/Jbc.M005847200  0.359
2000 van Horck FP, Ahmadian MR, Haeusler LC, Moolenaar WH, Kranenburg O. Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. The Journal of Biological Chemistry. 276: 4948-56. PMID 11058585 DOI: 10.1074/Jbc.M003839200  0.412
2000 Moolenaar WH. Development of our current understanding of bioactive lysophospholipids. Annals of the New York Academy of Sciences. 905: 1-10. PMID 10818436 DOI: 10.1111/J.1749-6632.2000.Tb06532.X  0.464
2000 Feiken E, van Etten I, Gebbink MF, Moolenaar WH, Zondag GC. Intramolecular interactions between the juxtamembrane domain and phosphatase domains of receptor protein-tyrosine phosphatase RPTPmu. Regulation of catalytic activity. The Journal of Biological Chemistry. 275: 15350-6. PMID 10809770 DOI: 10.1074/Jbc.275.20.15350  0.328
2000 Zondag GC, Reynolds AB, Moolenaar WH. Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn). The Journal of Biological Chemistry. 275: 11264-9. PMID 10753936 DOI: 10.1074/Jbc.275.15.11264  0.352
2000 Kranenburg O, Verlaan I, Moolenaar WH. Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase. The Journal of Biological Chemistry. 274: 35301-4. PMID 10585393 DOI: 10.1074/Jbc.274.50.35301  0.389
1999 Moolenaar WH. Bioactive lysophospholipids and their G protein-coupled receptors. Experimental Cell Research. 253: 230-8. PMID 10579925 DOI: 10.1006/Excr.1999.4702  0.446
1999 Kranenburg O, Poland M, van Horck FP, Drechsel D, Hall A, Moolenaar WH. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Molecular Biology of the Cell. 10: 1851-7. PMID 10359601 DOI: 10.1091/Mbc.10.6.1851  0.463
1999 Houssa B, de Widt J, Kranenburg O, Moolenaar WH, van Blitterswijk WJ. Diacylglycerol kinase theta binds to and is negatively regulated by active RhoA. The Journal of Biological Chemistry. 274: 6820-2. PMID 10066731 DOI: 10.1074/jbc.274.11.6820  0.3
1999 KRANENBURG O, VERLAAN I, MOOLENAAR WH. Gi-mediated tyrosine phosphorylation of Grb2 (growth-factor-receptor-bound protein 2)-bound dynamin-II by lysophosphatidic acid Biochemical Journal. 339: 11. DOI: 10.1042/Bj3390011  0.432
1999 KRANENBURG O, VERLAAN I, MOOLENAAR WH. Gi-mediated tyrosine phosphorylation of Grb2 (growth-factor-receptor-bound protein 2)-bound dynamin-II by lysophosphatidic acid Biochemical Journal. 339: 11-14. DOI: 10.1042/BJ3390011  0.325
1998 Ramakers GJ, Moolenaar WH. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Experimental Cell Research. 245: 252-62. PMID 9851865 DOI: 10.1006/Excr.1998.4224  0.397
1998 Giepmans BN, Moolenaar WH. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Current Biology : Cb. 8: 931-4. PMID 9707407 DOI: 10.1016/S0960-9822(07)00375-2  0.365
1998 Stam JC, Michiels F, van der Kammen RA, Moolenaar WH, Collard JG. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. The Embo Journal. 17: 4066-74. PMID 9670021 DOI: 10.1093/Emboj/17.14.4066  0.427
1998 Hirose M, Ishizaki T, Watanabe N, Uehata M, Kranenburg O, Moolenaar WH, Matsumura F, Maekawa M, Bito H, Narumiya S. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. The Journal of Cell Biology. 141: 1625-36. PMID 9647654 DOI: 10.1083/Jcb.141.7.1625  0.411
1998 Westermann AM, Havik E, Postma FR, Beijnen JH, Dalesio O, Moolenaar WH, Rodenhuis S. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 9: 437-42. PMID 9636836 DOI: 10.1023/A:1008217129273  0.341
1998 van Dijk MC, Postma F, Hilkmann H, Jalink K, van Blitterswijk WJ, Moolenaar WH. Exogenous phospholipase D generates lysophosphatidic acid and activates Ras, Rho and Ca2+ signaling pathways. Current Biology : Cb. 8: 386-92. PMID 9545198 DOI: 10.1016/S0960-9822(98)70157-5  0.461
1998 Postma FR, Hengeveld T, Alblas J, Giepmans BN, Zondag GC, Jalink K, Moolenaar WH. Acute loss of cell-cell communication caused by G protein-coupled receptors: a critical role for c-Src. The Journal of Cell Biology. 140: 1199-209. PMID 9490732 DOI: 10.1083/Jcb.140.5.1199  0.455
1998 Zondag GC, Postma FR, Etten IV, Verlaan I, Moolenaar WH. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. The Biochemical Journal. 605-9. PMID 9480864 DOI: 10.1042/BJ3300605  0.32
1998 Zondag GC, Moolenaar WH. Receptor protein tyrosine phosphatases: involvement in cell-cell interaction and signaling. Biochimie. 79: 477-83. PMID 9451448 DOI: 10.1016/S0300-9084(97)82739-3  0.352
1997 Westermann AM, Beijnen JH, Moolenaar WH, Rodenhuis S. Growth factors in human ovarian cancer Cancer Treatment Reviews. 23: 113-131. PMID 9225962 DOI: 10.1016/S0305-7372(97)90024-4  0.305
1997 Kranenburg O, Verlaan I, Hordijk PL, Moolenaar WH. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. The Embo Journal. 16: 3097-105. PMID 9214627 DOI: 10.1093/Emboj/16.11.3097  0.384
1997 Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. The Journal of Cell Biology. 137: 1603-13. PMID 9199174 DOI: 10.1083/Jcb.137.7.1603  0.459
1997 van Dijk M, Muriana FJ, van Der Hoeven PC, de Widt J, Schaap D, Moolenaar WH, van Blitterswijk WJ. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-zeta. The Biochemical Journal. 323: 693-9. PMID 9169602 DOI: 10.1042/Bj3230693  0.409
1997 Moolenaar WH, Kranenburg O, Postma FR, Zondag GC. Lysophosphatidic acid: G-protein signalling and cellular responses. Current Opinion in Cell Biology. 9: 168-73. PMID 9069262 DOI: 10.1016/S0955-0674(97)80059-2  0.419
1996 Zondag GC, Moolenaar WH, Gebbink MF. Lack of association between receptor protein tyrosine phosphatase RPTP mu and cadherins. The Journal of Cell Biology. 134: 1513-7. PMID 8830778 DOI: 10.1083/Jcb.134.6.1513  0.385
1996 Alblas J, Etten Iv, Moolenaar WH. Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism. The Embo Journal. 15: 3351-3360. DOI: 10.1002/J.1460-2075.1996.Tb00700.X  0.42
1996 Postma FR, Jalink K, Hengeveld T, Moolenaar WH. Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. The Embo Journal. 15: 2388-2392. DOI: 10.1002/J.1460-2075.1996.Tb00595.X  0.392
1996 Postma FR, Jalink K, Hengeveld T, Bot AGM, Alblas J, Jonge HRD, Moolenaar WH. Serum-induced membrane depolarization in quiescent fibroblasts: activation of a chloride conductance through the G protein-coupled LPA receptor. The Embo Journal. 15: 63-72. DOI: 10.1002/J.1460-2075.1996.Tb00334.X  0.44
1995 Jalink K, Hordijk PL, Moolenaar WH. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochimica Et Biophysica Acta. 1198: 185-96. PMID 7819274 DOI: 10.1016/0304-419X(94)90013-2  0.318
1995 Zondag GC, Koningstein GM, Jiang YP, Sap J, Moolenaar WH, Gebbink MF. Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. The Journal of Biological Chemistry. 270: 14247-50. PMID 7782276 DOI: 10.1074/Jbc.270.24.14247  0.379
1995 Jalink K, Hengeveld T, Mulder S, Postma FR, Simon MF, Chap H, van der Marel GA, van Boom JH, van Blitterswijk WJ, Moolenaar WH. Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. The Biochemical Journal. 307: 609-16. PMID 7733903 DOI: 10.1042/Bj3070609  0.408
1995 Alblas J, van Etten I, Khanum A, Moolenaar WH. C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. Role of receptor phosphorylation in signal attenuation. The Journal of Biological Chemistry. 270: 8944-51. PMID 7721803 DOI: 10.1074/Jbc.270.15.8944  0.438
1995 Moolenaar WH. Lysophosphatidic acid signalling. Current Opinion in Cell Biology. 7: 203-10. PMID 7612272 DOI: 10.1016/0955-0674(95)80029-8  0.348
1995 Gebbink MF, Zondag GC, Koningstein GM, Feiken E, Wubbolts RW, Moolenaar WH. Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact. The Journal of Cell Biology. 131: 251-60. PMID 7559782 DOI: 10.1083/Jcb.131.1.251  0.379
1994 Jalink K, van Corven EJ, Hengeveld T, Morii N, Narumiya S, Moolenaar WH. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. The Journal of Cell Biology. 126: 801-10. PMID 8045941 DOI: 10.1083/Jcb.126.3.801  0.447
1994 Limatola C, Schaap D, Moolenaar WH, van Blitterswijk WJ. Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. The Biochemical Journal. 304: 1001-8. PMID 7818462 DOI: 10.1042/Bj3041001  0.403
1994 Gebbink MF, Verheijen MH, Zondag GC, van Etten I, Moolenaar WH. Purification and characterization of the cytoplasmic domain of human receptor-like protein tyrosine phosphatase RPTP mu. Biochemistry. 32: 13516-22. PMID 7504951 DOI: 10.1021/Bi00212A017  0.416
1993 Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. The Biochemical Journal. 291: 677-80. PMID 8489494 DOI: 10.1042/Bj2910677  0.38
1993 Jalink K, Moolenaar WH, Van Duijn B. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae. Proceedings of the National Academy of Sciences of the United States of America. 90: 1857-61. PMID 8383331 DOI: 10.1073/Pnas.90.5.1857  0.439
1993 van Corven EJ, Hordijk PL, Medema RH, Bos JL, Moolenaar WH. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 90: 1257-61. PMID 7679495 DOI: 10.1073/Pnas.90.4.1257  0.454
1992 van Corven EJ, van Rijswijk A, Jalink K, van der Bend RL, van Blitterswijk WJ, Moolenaar WH. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. The Biochemical Journal. 281: 163-9. PMID 1731751 DOI: 10.1042/Bj2810163  0.358
1992 van der Bend RL, de Widt J, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin. The Biochemical Journal. 285: 235-40. PMID 1637305 DOI: 10.1042/Bj2850235  0.435
1992 van der Bend RL, de Widt J, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. Metabolic conversion of the biologically active phospholipid, lysophosphatidic acid, in fibroblasts. Biochimica Et Biophysica Acta. 1125: 110-2. PMID 1567902 DOI: 10.1016/0005-2760(92)90163-P  0.358
1992 Fernhout BJ, Dijcks FA, Moolenaar WH, Ruigt GS. Lysophosphatidic acid induces inward currents in Xenopus laevis oocytes; evidence for an extracellular site of action. European Journal of Pharmacology. 213: 313-5. PMID 1521564 DOI: 10.1016/0014-2999(92)90698-4  0.376
1992 Verheijden GF, Moolenaar WH, Ploegh HL. Retention of epidermal growth factor receptors in the endoplasmic reticulum of adenovirus-infected cells. The Biochemical Journal. 115-21. PMID 1371666 DOI: 10.1042/Bj2820115  0.387
1992 Moolenaar WH, van der Bend RL, van Corven EJ, Jalink K, Eichholtz T, van Blitterswijk WJ. Lysophosphatidic acid: a novel phospholipid with hormone- and growth factor-like activities. Cold Spring Harbor Symposia On Quantitative Biology. 57: 163-7. PMID 1339655 DOI: 10.1101/Sqb.1992.057.01.021  0.331
1992 Jalink K, Moolenaar WH. Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. The Journal of Cell Biology. 118: 411-9. PMID 1321160 DOI: 10.1083/Jcb.118.2.411  0.485
1992 van der Bend RL, Brunner J, Jalink K, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. The Embo Journal. 11: 2495-501. PMID 1321033 DOI: 10.1002/J.1460-2075.1992.Tb05314.X  0.446
1992 Moolenaar WH, Jalink K. Membrane Potential Changes in the Action of Growth Factors Cellular Physiology and Biochemistry. 2: 189-195. DOI: 10.1159/000154640  0.3
1991 Verheijden GF, Verlaan I, Schlessinger J, Moolenaar WH. Epidermal growth factor-induced phosphoinositide hydrolysis in permeabilized 3T3 cells: lack of guanosine triphosphate dependence and inhibition by tyrosine-containing peptides. Cell Regulation. 1: 615-20. PMID 1964091 DOI: 10.1091/Mbc.1.9.615  0.432
1991 Moolenaar WH. Mitogenic action of lysophosphatidic acid. Advances in Cancer Research. 57: 87-102. PMID 1950708 DOI: 10.1016/S0065-230X(08)60996-3  0.4
1991 Gebbink MFBG, Etten Iv, Hateboer G, Suijkerbuijk R, Beijersbergen RL, Kessell AGv, Moolenaar WH. Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase. Febs Letters. 290: 123-130. PMID 1655529 DOI: 10.1016/0014-5793(91)81241-Y  0.352
1990 Eichholtz T, Alblas J, van Overveld M, Moolenaar W, Ploegh H. A pseudosubstrate peptide inhibits protein kinase C-mediated phosphorylation in permeabilized Rat-1 cells. Febs Letters. 261: 147-50. PMID 2307230 DOI: 10.1016/0014-5793(90)80657-5  0.34
1990 Bellot F, Moolenaar W, Kris R, Mirakhur B, Verlaan I, Ullrich A, Schlessinger J, Felder S. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. The Journal of Cell Biology. 110: 491-502. PMID 2298813 DOI: 10.1083/Jcb.110.2.491  0.386
1990 Tilly BC, Tertoolen LG, Remorie R, Ladoux A, Verlaan I, de Laat SW, Moolenaar WH. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors. The Journal of Cell Biology. 110: 1211-5. PMID 2182646 DOI: 10.1083/Jcb.110.4.1211  0.413
1990 Verheijden GF, Verlaan I, van Iersel MJ, Moolenaar WH. Second messenger modulation of epidermal growth factor receptor function does not occur at the level of receptor dimerization. The Biochemical Journal. 271: 215-21. PMID 2171499 DOI: 10.1042/Bj2710215  0.419
1990 Tilly BC, Lambrechts AC, Tertoolen LG, de Laat SW, Moolenaar WH. Regulation of phosphoinositide hydrolysis induced by histamine and guanine nucleotides in human HeLa carcinoma cells. Calcium and pH dependence and inhibitory role of protein kinase C. Febs Letters. 265: 80-4. PMID 2163883 DOI: 10.1016/0014-5793(90)80888-P  0.397
1990 Tilly BC, Tertoolen LG, Lambrechts AC, Remorie R, de Laat SW, Moolenaar WH. Histamine-H1-receptor-mediated phosphoinositide hydrolysis, Ca2+ signalling and membrane-potential oscillations in human HeLa carcinoma cells. The Biochemical Journal. 266: 235-43. PMID 2155607 DOI: 10.1042/Bj2660235  0.381
1990 Moolenaar WH, van Corven EJ. Growth factor-like action of lysophosphatidic acid: mitogenic signalling mediated by G proteins. Ciba Foundation Symposium. 150: 99-106; discussion 1. PMID 2115427 DOI: 10.1002/9780470513927.ch7  0.331
1989 Defize LH, Boonstra J, Meisenhelder J, Kruijer W, Tertoolen LG, Tilly BC, Hunter T, van Bergen en Henegouwen PM, Moolenaar WH, de Laat SW. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. The Journal of Cell Biology. 109: 2495-507. PMID 2553748 DOI: 10.1083/Jcb.109.5.2495  0.383
1989 van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59: 45-54. PMID 2551506 DOI: 10.1016/0092-8674(89)90868-4  0.444
1988 Tilly BC, van Paridon PA, Verlaan I, de Laat SW, Moolenaar WH. Epidermal-growth-factor-induced formation of inositol phosphates in human A431 cells. Differences from the effect of bradykinin. The Biochemical Journal. 252: 857-63. PMID 3138977 DOI: 10.1042/Bj2520857  0.378
1988 Schlessinger J, Ullrich A, Honegger AM, Moolenaar WH. Signal transduction by epidermal growth factor receptor. Cold Spring Harbor Symposia On Quantitative Biology. 53: 515-9. PMID 2855491 DOI: 10.1101/Sqb.1988.053.01.059  0.347
1988 Moolenaar WH, Bierman AJ, Tilly BC, Verlaan I, Defize LH, Honegger AM, Ullrich A, Schlessinger J. A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction. The Embo Journal. 7: 707-710. DOI: 10.1002/J.1460-2075.1988.Tb02866.X  0.421
1987 Tilly BC, van Paridon PA, Verlaan I, Wirtz KW, de Laat SW, Moolenaar WH. Inositol phosphate metabolism in bradykinin-stimulated human A431 carcinoma cells. Relationship to calcium signalling. The Biochemical Journal. 244: 129-35. PMID 3663107 DOI: 10.1042/Bj2440129  0.307
1987 Tertoolen LG, Tilly BC, Irvine RF, Moolenaar WH. Electrophysiological responses to bradykinin and microinjected inositol polyphosphates in neuroblastoma cells. Possible role of inositol 1,3,4-trisphosphate in altering membrane potential. Febs Letters. 214: 365-9. PMID 3494634 DOI: 10.1016/0014-5793(87)80089-3  0.306
1986 Moolenaar WH, Defize LH, de Laat SW. Calcium in the action of growth factors. Ciba Foundation Symposium. 122: 212-31. PMID 3792139 DOI: 10.1002/9780470513347.ch13  0.313
1986 Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Bierman AJ, de Laat SW. Growth factor-like action of phosphatidic acid. Nature. 323: 171-3. PMID 3748188 DOI: 10.1038/323171A0  0.33
1986 Defize LH, Moolenaar WH, van der Saag PT, de Laat SW. Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies. The Embo Journal. 5: 1187-92. PMID 3015588 DOI: 10.1002/J.1460-2075.1986.Tb04345.X  0.399
1986 Mummery CL, Feijen A, Moolenaar WH, van den Brink CE, de Laat SW. Establishment of a differentiated mesodermal line from P19 EC cells expressing functional PDGF and EGF receptors. Experimental Cell Research. 165: 229-42. PMID 3011479 DOI: 10.1016/0014-4827(86)90547-1  0.446
1986 Moolenaar WH, Defize LHK, Van Der Saag PT, De Laat SW. Chapter 8 The Generation of Ionic Signals by Growth Factors Current Topics in Membranes and Transport. 26: 137-156. DOI: 10.1016/S0070-2161(08)60730-3  0.384
1984 Moolenaar WH, Tertoolen LGJ, De Laat SW. Phorbol ester and diacylglycerol mimic growth factors in raising cytoplasmic pH Nature. 312: 371-374. PMID 6095096 DOI: 10.1038/312371A0  0.372
1983 Moolenaar WH, Tsien RY, Van der Saag PT, De Laat SW. Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts Nature. 304: 645-648. PMID 6410286 DOI: 10.1038/304645A0  0.301
1983 Boonstra J, Moolenaar WH, Harrison PH, Moed P, van der Saag PT, de Laat SW. Ionic responses and growth stimulation induced by nerve growth factor and epidermal growth factor in rat pheochromocytoma (PC12) cells. The Journal of Cell Biology. 97: 92-8. PMID 6306015 DOI: 10.1083/Jcb.97.1.92  0.331
1979 Moolenaar WH, De Laat SW, van der Saag PT. Serum triggers a sequence of rapid ionic conductance changes in quiescent neuroblastoma cells Nature. 279: 721-723. PMID 450122 DOI: 10.1038/279721A0  0.324
Show low-probability matches.